Background--Recent studies suggest that adult cardiac progenitor cells (CPCs) can produce new cardiac cells. Such cell formation requires an intricate coordination of progenitor cell proliferation and commitment, but the molecular cues responsible for this regulation in CPCs are ill defined.
T he adult mammalian heart has a limited capacity of cell replacement, which in case of injury, such as myocardial infarction, is insufficient to restore cardiac cellularity and function. The resulting heart failure is a major cause of morbidity and mortality, and an intense search for therapeutic strategies to promote cardiac regeneration is currently ongoing. Such an approach, however, requires a clear understanding of the molecular mechanisms orchestrating cardiac cell replacement. It is now well established that the adult heart harbors cardiac progenitor cells (CPCs), which are -in principal-capable of self-renewal 1,2 and differentiation into cardiac lineages, including cardiomyocytes, endothelial cells, and vascular smooth muscle cells. A variety of markers and techniques for their identification and isolation have been reported. 3 In preclinical studies, various populations, including c-kit + CPCs, cardiosphere-derived cells, and cardiac side population (SP) CPCs, either endogenously or on in vitro expansion and transplantation, contribute to cardiac cell renewal after injury. [4] [5] [6] [7] Clinical trials using c-kit + CPCs and cardiosphere-derived cells to induce regeneration of the postinfarct myocardium in humans have been initiated. 8, 9 Freshly isolated CPCs are low in numbers and require amplification before being transplanted into the injured heart for therapeutic application. Isolated CPCs can be readily expanded in vitro while keeping their multilineage differentiation potential. As shown for various CPC populations, including c-kit + and SP-CPCs, successful differentiation on in vitro expansion requires additional steps and stimuli, including extracellular matrix (ECM), growth factors, and hormones. 4, 10, 11 In addition, loss of multipotency associates with decreased cellular proliferation capacity. 12 The identification of molecular cues that are responsible for the CPC fate transition from a proliferating (ie, expanding) to a committed, ready-to-differentiate phenotype, and that are also common to different CPC populations, will help identify therapeutic targets that could be exploited to promote cardiac regeneration based on new cell formation. Cell fate decisions are characterized by dynamic shifts in the transcriptome that occur during specific phases of the cell cycle. Regulators of the cell cycle play an important role in the coordination of the cell cycle and gene expression, hence balancing proliferation and differentiation. An antagonistic relationship between cell cycle regulators and lineage gene expression was first described in skeletal muscle, 13 but proliferation and differentiation decisions are complex and executed in a cell-and tissue-dependent manner. 12 How this coordination evolves in CPCs and what molecular cues regulate their fate transition are still poorly understood. The ECM is a major instructor of stem cell fate in terms of selfrenewal and lineage specification. 14 It has recently been shown that proliferation of c-kit + CPCs is enhanced by fibronectin (FN) 15 and that stiff matrix increases proliferation but diminishes differentiation of SP-CPCs. [16] [17] [18] Herein, we used a simplified model of ECM-instructed CPC fate, using laminin (LN) and FN as substrates to produce two distinct phenotypes of c-kit + CPCs. These two phenotypes differed with respect to their proliferation rate, which was lower, and their commitment status, which was higher on LN compared with FN. To examine the early molecular cues of CPC lineage commitment, we investigated the early (<2 hours) transcriptomic response to CPC adhesion with particular emphasis on cell cycle regulatory genes. We identify the cell cycle regulator polo-like kinase 2 (Plk2) as one of the most strongly downregulated genes on LN, and report a role for Plk2 as coordinator of proliferation and lineage commitment of c-kit + CPCs. To test whether Plk2 qualifies as a common fate cue of different populations of CPCs, this molecular regulation was validated in SP-CPCs, a population that is distinct from c-kit + CPCs on their molecular signature. 19 
Methods

CPC Isolation and Culture
Rat CPCs (rCPCs) were a kind gift from Drs Piero Anversa and Annarosa Leri. They were established previously in the laboratory of Dr Anversa 20 and used in a cell line-like manner, such as different passages of cells were used for all experiments to support reproducibility. rCPCs were cultured in F12 medium (Thermo Fisher) containing 10% fetal bovine serum (FBS), 10 lg/L leukemia inhibitory factor (Millipore), 10 ng/mL basic fibroblast growth factor (PeproTech), 5 U/L erythropoietin and 0.2 mmol/L glutathione (both from Sigma) at 37°C with 5% CO 2 . Isolation of Sca1 + /CD31 À SP-CPCs from mice (mCPCs)
was performed according to the Guide for the Care and Use of Laboratory Animals and with the approval of the Swiss Cantonal Authorities. Mice were euthanized by intraperitoneal injection of sodium pentobarbital (150-200 mg/kg body weight), followed by rapid excision of the heart. Cardiomyocyte-depleted cardiac cell suspensions were prepared, as previously described, 10 with some modifications. In brief, minced cardiac tissue from 4 mice was digested with 0.1% collagenase B (Roche) and 2. What Are the Clinical Implications?
• Molecules involved in the fate transition from a proliferating (ie, expanding) to a committed, ready to differentiate, cardiac progenitor cell could be therapeutically targeted to promote cardiac regeneration based on new cell formation.
• Further studies are needed to examine whether the Yesassociated protein/Plk2 axis qualifies as a potential target to therapeutically promote neovascularization.
cell sorting to exclude dead cells. Sorting was performed using a BD Influx (BD Biosciences). The Hoechst dye was excited using UV 355 nm, fluorescence emission was collected with a 460/50-nm band-pass filter (Hoechst blue) and a 670/30-nm band-pass filter (Hoechst red). Verapamil (Sigma, 100 lmol/L) was used as negative control, as it suppresses extrusion of Hoechst. Sca1 + /CD31 À SP-mCPCs were sorted and amplified using minimal essential medium a (Thermo Fisher) containing 20% FBS at 37°C with 5% CO 2 . SPmCPCs from passages 7 to 20 from 3 different isolations were used for all experiments, with each isolation containing cells from 4 mice. Experiments were performed on culture dishes coated with LN (Sigma #L2020, ready-made in solution) and FN (Sigma #F4759, diluted in water).
Polymerase Chain Reaction Analysis for Cell Characterization
Whole hearts were cut into small pieces and homogenized with a polytron PT-DA 07/2EC-E107 homogenizer (Kinematica, Switzerland). Bone marrow was taken from rat femur. RNA was extracted from whole heart homogenates, bone marrow, mouse embryonic stem cells (used as positive control for stemness genes), and cultured rCPCs and SPmCPCs using TRI Reagent (Sigma). RNA was treated with a DNAse kit (Promega), according to the manufacturer's protocol. RNA (2 lg) was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer's instructions. Polymerase chain reaction (PCR) was performed on a thermocycler (Biometra, Germany). Primer sequences (all from Microsynth) are described in Table S1 . PCR was performed under the following conditions: 95°C for 2 minutes; X cycles of 95°C for 15 seconds; Y°C for 30 seconds; 72°C for 40 seconds; and a final elongation at 72°C for 10 minutes to amplify the genes (rat: Abcg2, Kit, Pou5f1, Abcb1a, Abcb1b, Nkx2.5, Gata4, Myh7b, Tnni3, Vwf, Pecam1, Gaphd, Tbx18, Wt1, Aldh1a2, and Tcf21); and 95°C for 2 minutes; X cycles of 94°C for 45 seconds; Y°C for 45 seconds; 72°C for 60 seconds; and a final elongation at 72°C for 10 minutes (rat: Nanog and Myh6; and all mouse genes). PCR products were then subjected to electrophoresis in a 2% agarose gel. X and Y are described in Table S1 number (#) of cycles and°C, respectively. 
Tube Formation Assay
Plates (96 wells) were coated with 100 lL of matrigel (Corning) per well, and 4910 4 cells in 100 lL of EGM-2 medium were seeded on the gel and incubated for 24 hours. Cells were cultured with EGM-2 for 3 weeks before being used for tube formation assays. Imaging was performed with Olympus IX50. The number of meshes and nodes was counted as described by DeCicco-Skinner et al. 23 
ECM-Cell Interaction Experiments
rCPCs were cultured in 75-mL flasks with F12 medium containing 10% FBS and the indicated supplements for 2 to 3 days. Cells were then trypsinized and seeded on culture dishes that were pre-coated with 10 lg/mL of either LN or FN at a cell density of <60% confluency in F12 medium containing 0.1% FBS and supplements, and incubated for the times indicated. mCPCs were cultured in 75-mL flasks with minimal essential medium a containing 20% FBS for 3 to 5 days, and the medium was changed every 2 to 3 days. Cells were trypsinized and seeded on LN or FN (10 lg/mL)-coated dishes at <60% confluency in minimal essential medium a with 0.1% to 0.5% FBS, and incubated for the times indicated.
Cell Proliferation and Viability
rCPCs were seeded on LN-or FN-coated dishes with F12 medium containing 0.1% FBS and indicated supplements, and cells were counted after 2 and 3 days. For assessment of viability, cells were stained with trypan blue after 2 and 3 days, and trypan blue-positive (dead) and trypan bluenegative (viable) cells were quantified. Viable cells are given in relation to the total cell number.
Quantitative Reverse Transcription-PCR Analysis
Total RNA was isolated using TRI Reagent, and 2 lg of RNA were reverse transcribed using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems), according to the manufacturer's instructions. The amplification was performed using Power SYBR Green PCR Master Mix and the respective primers (all from Microsynth, Table S1 ), with an ABI PRISM 7500 sequence detection system (Applied Biosystems). mRNA levels were calculated using the comparative C T method with 18S rRNA as endogenous control. Data are presented as ÀddCT values (corresponding to the log2-fold induction).
3-Dimensional Cell-Based Constructs
rCPCs were loaded on 3-dimensional collagen discs of 3-mm thickness and 8-mm diameter (Ultrafoam ™ ) pre-coated for %18 hours with 10 lg/mL of either LN or FN using a perfusion bioreactor with direct perfusion of the culture medium through the scaffold pores, as previously described. 24 rCPCs were seeded at a density of 14.6910 6 cells/cm 3 , corresponding to 2.2910 6 cells per scaffold, with a bidirectional flow rate of 1 mL/min for 4 hours, and cultured at 0.1 mL/min for the following 24 hours. 25 The culture medium was supplemented with 1% FBS. , and the qCount function, we quantified gene expression as the number of reads that started within any annotated exon of a gene. The differentially expressed genes were identified using the edgeR package (version 3.10.5). 29 To remove the batch effect from the data, we included it into the fitted model. RNA sequencing data have been deposited at the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE77231.
Immunocytochemistry and Immunohistochemistry
Proteasome Inhibitor Assay rCPCs were incubated for 2 hours with 10 lmol/L of MG132 (Sigma) or dimethyl sulfoxide. Cells were then trypsinized and seeded on LN-or FN-coated dishes with F12 medium containing 0.1% FBS, leukemia inhibitory factor, basic fibroblast growth factor, erythropoietin, and glutathione, as indicated above (CPC isolation and culture).
Immunoprecipitation
Cytosolic lysates were prepared with CytoBuster (Novagen) containing PhosSTOP and Complete Protease Inhibitor Cocktail and incubated on ice for 50 minutes, during which they were vortexed every 10 minutes for 10 seconds, and centrifuged at 15 000g for 5 minutes at 4°C. Immunoprecipitation was performed with anti-YAP antibody (Cell Signaling #14074, 5 lL/sample), anti-rabbit IgG (Cell Signaling #2729), and Protein G Sepharose 4 fast flow (GE Healthcare).
Immunoprecipitates were washed with CytoBuster and eluted at 95°C for 5 minutes. Samples were then separated by SDS-PAGE.
RNA Interference
Cells were cultured overnight, transfected with 20 to 40 nmol/L siRNA (from Qiagen: Control: #SI03650318, rPlk2: #SI01962163) using DharmaFECT 1 (Dharmacon), and maintained for 2 days before experiments.
Plasmid Transfections
pCMV-flag S127A YAP was a gift from Dr Kunliang Guan
30
(Addgene plasmid #27370). pCMV-flag S127A YAP, pCMVMyc-flag-rPlk2 plasmid (OriGene #RR203879) and pCMVMyc-flag plasmid (OriGene #PS100001) were transfected using Lipofectamin LTX (Thermo Fisher), according to the manufacturer's protocol. G418 (500 lg/mL, Thermo Fisher) was used for selection of drug resistant clones.
3-[4,5-Dimethylthiazol-2-yl]-2,5 Diphenyl Tetrazolium Bromide Assay
The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay was performed using the cell proliferation kit I (Roche), according to the manufacturer's protocol.
Statistical Analyses
Unless otherwise indicated, data are presented as mean AESEM. Statistical analyses were performed with GraphPad Prism version 6 software (GraphPad) on nonnormalized (ie, raw) data for all data sets with n≥4 independent experiments using non-parametric testing, as indicated. Expression differences of the quantitative PCR data were tested for significance based on dCT values. P<0.05 was considered statistically significant.
Results
LN Slows CPC Proliferation and Induces the Expression of Cardiac Lineage-Specific Genes
The ECM is an important regulator of cell fate decisions, 31, 32 and biomechanical properties of the ECM have previously been linked to CPC fate. 17, 18 However, the contribution of individual ECM proteins to CPC fate is less understood. We, therefore, sought to test how LN and FN affect proliferation and lineage commitment of CPCs. c-kit + rCPCs and Sca1 + / CD31 À SP-mCPCs were plated on plastic dishes that were either noncoated or precoated with LN or FN (10 lg/mL). Inlaboratory characterization of c-kit + rCPCs and Sca1 + /CD31 À SP-mCPCs, showing gene and surface marker expression, clonogenicity, cardio-stem-sphere formation, and endothelial and cardiomyogenic differentiation, is depicted in Figure S1 . Both cell types have previously been shown to exhibit cardiomyogenic and vasculogenic differentiation potential in vitro and in vivo, 4, 5, 7, 10, 20, 33 although meaningful in vivo cardiomyogenic differentiation of c-kit + CPCs is currently highly disputed. 34, 35 Cells were plated at low density (<60% confluency) to avoid cell-cell contact and under low serum conditions (≤0.5% FBS) to prevent activation of growth factordependent pathways, which both could act as potential confounders of adhesion-dependent CPC regulation. To assess substrate-dependent proliferation of CPCs, identical numbers of rCPCs were plated on LN-or FN-coated dishes, and cells were counted at days 2 and 3. We observed a continuous increase in cell numbers over time on FN, which was markedly blunted on LN ( Figure 1A ). The lower cell numbers on LN were not because of cell death, as cell viability was comparable between LN and FN and virtually stable throughout the 3-day follow-up ( Figure 1B ). We further sought to test whether the lower cell proliferation on LN may be associated with initiation of lineage specification. rCPCs were plated on LN and FN for 24 hours. Gene expression of the cardiac transcription factor GATA binding protein 4 (Gata4), the cardiomyogenic markers troponin I and b-myosin heavy chain, and the endothelial markers vWF and CD31 (Pecam1) was measured. While there was a nonsignificant trend towards higher expression of Gata4, troponin I, and b-myosin heavy chain in CPCs on LN than on FN, gene expression of both vWF and CD31 was significantly upregulated on LN as compared with FN ( Figure 1C and Figure S2A ), indicative of enhanced lineage commitment with a higher propensity towards the endothelial than cardiomyogenic lineage at low serum conditions and in the absence of facilitating factors. Similar experiments with SP-mCPCs yielded comparable results ( Figure 1D and Figure S2B ). To test whether LN and FN regulate cell fate in a similar manner in a more physiological culture system, 3-dimensional rCPC cultures were created using scaffolds precoated with LN ( Figure S3A and S3B) or FN in a perfusion-based bioreactor. While under perfusion on both LN and FN, the expression of endothelial lineage markers increased compared with nonadhering rCPCs in suspension, rCPCs cultured on LN-coated scaffolds showed higher gene expression of vWF and CD31 ( Figure S3C ). Taken together and similar to pluripotent stem cells, 36, 37 LN and FN appear to play an active role in CPC fate decision.
LN Facilitates Endothelial Differentiation of CPCs
Under growth conditions, rCPCs maintained their shape ( Figure S4A ), but grew confluent after 3 weeks in culture, exhibiting a cobblestone pattern similar to epicardial progenitor cells when cultured on LN or FN and kept under low serum within the first 24 hours (Figure 2A ). However, although rCPCs expressed T-box 18 (Tbx18) at a similar level as found in the neonatal heart, they did not express other epicardial markers, such as Wilms tumor protein, aldehyde dehydrogenase 1 family member a2, and transcription factor 21, neither at baseline ( Figure S4B ) nor after culturing (data not shown). To test whether the observed differences in the expression levels of lineage genes, which were more pronounced for the endothelial lineage, translate into differences in differentiation potential, cells were plated at low density and under low serum conditions on LN or FN for 24 hours, followed by 3 weeks of culturing in endothelial differentiation medium. Although rCPCs did not express vWF protein when cultured in growth medium ( Figure S4C ), rCPCs on both LN and FN adopted an endothelial cell phenotype after 3 weeks in differentiation medium, with more pronounced expression of vWF protein in rCPCs on LN than on FN (Figure 2A and 2B) . Similarly, rCPCs that were primed and differentiated on LN had a higher capacity of tube formation than rCPCs on FN ( Figure 2C and 2D). These findings suggest a sustained effect of LN facilitating endothelial differentiation of CPCs.
YAP Is Differentially Regulated in CPCs on LN Versus FN
General fluctuations in the transcriptome contribute to lineage choice. 38 The transcriptional coactivator YAP can act as an intracellular checkpoint in the integration of (bio) mechanical signals by transducing ECM signals into the nucleus. YAP is regulated by the Hippo or noncanonical pathways and responds to cell adhesion and biomechanical properties of the substrate. 39, 40 In addition, YAP is a known regulator of cell proliferation in many cell types, including organ-specific progenitor cells, [41] [42] [43] [44] and its expression is decreased during embryonic stem cell differentiation. 45 We, YAP shuttles between the cytosol and the nucleus, where it exerts its activity as a transcriptional coactivator. Phosphorylation of YAP at serine 127 leads to the cytosolic sequestration of YAP, where it can be proteasomally degraded. 46 Paralleling the degree of YAP protein loss, the ratio of serine 127-phosphorylated YAP/total YAP was significantly increased in CPCs plated on LN as compared with FN ( Figure 3A through 3F) . Furthermore, the percentage of cells exhibiting predominantly cytosolic localization of YAP, 
YAP Inactivation on LN Is Associated With Early Differences in Gene Expression
YAP is a transcriptional coactivator, and its nuclear localization is required for YAP activity and YAP-dependent gene expression. We, therefore, sought to identify potential YAP target genes that could mediate the adhesion-dependent CPC phenotype in our model. rCPCs were either kept nonadhering in suspension or plated on LN, FN, or noncoated dishes for 2 hours, and early response gene expression was assessed by RNA sequencing (n=3). Gene expression was remarkably changed through cell adhesion to all 3 substrates (LN, FN, and noncoated dishes) as compared with CPCs in suspension. In total, 4984 genes were significantly (adjusted P<0.05) regulated on LN, 2395 on FN, and 3261 on noncoated dishes when compared with suspension. Because nuclear YAP was depleted on LN and enriched on FN, we further compared gene regulation on LN versus FN. Ninety-four genes were significantly different between LN and FN (adjusted P<0.05; Table S2 ). Among the top-ranked gene sets enriched were YAP conserved signature (CORDENON-SI_YAP_CONSERVED_SIGNATURE; Figure S5A ) and genes related to the YAP-interacting transcription factor TEAD1 (WGGAATGY_V$TEF1_Q6; Figure S5B ), whereby the vast majority of the genes were downregulated on LN versus FN for both sets. To identify potential target genes directly downregulated in response to YAP inactivation, genes that were at least 1 log2-fold downregulated on LN versus FN (17 genes; Table) , but showed no significant regulation on FN versus suspension, were further examined (9 genes, marked with an asterisk). The 3 top-ranked genes, which all showed >1.5 log2-fold downregulation on LN versus FN, were cysteinerich angiogenic inducer 61 (Cyr61), connective tissue growth factor (Ctgf ), and Plk2. To confirm the adhesion-dependent regulation of these 3 candidate genes, we performed single gene expression analyses by quantitative reverse transcription-PCR for Cyr61, Ctgf, and Plk2 in suspended rCPCs and after plating on LN and FN. Consistent with the results from RNA sequencing, single gene expression analyses showed downregulation of all 3 genes on LN ( Figure 4A through 4C) , and this was also true in mCPCs ( Figure 4D through 4F) . Plk2 is serum inducible. 47 To avoid growth factor and/or mitogenic stimulation, we performed our experiments under low serum conditions, but we observed similar regulation of YAP and Plk2 when 10% FBS was used. However, these results did not reach statistical significance ( Figure 4G through 4I ). Cyr61 and Ctgf have previously been identified as YAP target genes, 44, 48 but little is known about the regulation and role of Plk2. We, therefore, tested whether stabilization of YAP protein allows for mRNA levels of the known YAP target genes Cyr61 and Ctgf, and of the newly identified candidate gene Plk2, to be maintained on LN. On cytosolic retention, YAP can be ubiquitinated and proteasomally degraded. Consistently, YAP ubiquitination was present in rCPCs plated on LN for 30 minutes ( Figure 5A) , and under treatment with MG132, a cell-permeable proteasome inhibitor, YAP protein abundance Figure 5B ). Interestingly, although mRNA levels of Cyr61 were not rescued in the presence of MG132 ( Figure 5C ), the LN-induced decrease of Ctgf and Plk2 mRNA was attenuated ( Figure 5D and 5E), suggesting that Plk2 mRNA levels depend on YAP stability in our model. To corroborate YAP dependency of Plk2 regulation, rCPCs were transfected with mutant YAP, in which serine 127 is replaced by alanine (Flag-hYAPS127A), preventing the serine 127 phosphorylation-induced cytosolic sequestration of YAP.
Transfection with this construct significantly upregulated Plk2 mRNA, supporting that Plk2 may represent a to date unrecognized downstream effector of YAP ( Figure 5F and 5G).
Loss and Gain of Function of Plk2 Affect CPC Proliferation and Lineage Commitment
While YAP has been implicated in cell proliferation and differentiation in various cell types, the role of Plk2 in the and reduces its nuclear availability. A through F, YAP phosphorylation and protein abundance depending on the substrate. Rat cardiac progenitor cells (rCPCs) (A through C; n=5 different passages) and side population mouse CPCs (SP-mCPCs) (D through F; n=4 different passages from at least 2 different isolations) were plated on LN-or FN-coated dishes with 0.1% fetal bovine serum for 2 hours, and total and phosphorylated (serine 127) YAP (tYAP and pYAP, respectively) was detected by immunoblotting. Friedman test, followed by Dunn's test, on nonnormalized data for rCPCs: **P<0.01 for tYAP/GAPDH LN vs CPCs in suspension (Sus.), and *P<0.05 for pYAP/tYAP LN vs FN; for SP-mCPCs: **P<0.01 for tYAP/GAPDH LN vs Sus., and for pYAP/tYAP LN vs FN. G and H, Doseresponse to different concentrations of LN coating. rCPCs were plated for 1 hour on dishes precoated with the indicated concentrations of LN, and YAP protein was assessed by immunoblotting (n=5). 
Sus. regulation of cell fate is less clear. Plk2 mRNA and protein are upregulated during the G 1 and early S phase of the cell cycle, and their activation facilitates cell cycle progression, thereby regulating cell proliferation. 49 To assess whether Plk2 qualifies as mediator of the LN-induced CPC phenotype, we first examined the effects of Plk2 knockdown by siRNA on rCPC proliferation and expression of cardiac lineage markers. Although knockdown of Plk2 was only moderate ( Figure 6A , 6B, and 6D), Plk2 siRNA blunted CPC proliferation on FN ( Figure 6C ). In addition, Plk2 siRNA induced the expression of cardiomyogenic and endothelial lineage markers ( Figure 6E ) in the absence of permissive factors, such as differentiation medium. These findings show that downregulation of Plk2 gene expression is sufficient to mimic the CPC phenotype observed on LN and suggest a so far unknown role for Plk2 in the regulation of CPC fate. Next, we sought to test whether overexpression of Plk2 may revert the decreased cell proliferation on LN and diminish CPC lineage commitment. mCPCs were transfected with Plk2 plasmid, and cell proliferation was assessed on LN after 24 hours by MTT assay. Consistent with our hypothesis, MTT reduction was higher in Flag-Plk2-expressing mCPCs as compared with control ( Figure 6F and 6G) . Furthermore, expression of endothelial and-to a lesser degree-cardiomyogenic lineage markers was diminished in Flag-Plk2-expressing rCPCs ( Figure 6H and 6I). The observed differences in lineage gene expression are strongly suggestive of an inverse relationship between Plk2 and lineage gene expression in both directions (ie, not only when Plk2 is downregulated), but our results did not reach statistical significance.
Discussion
This report is unique in that it focuses on the early molecular events in the process of CPC lineage commitment and differentiation. Using a simplified model of matrix proteininstructed CPC fate, we identify Plk2 among a set of genes that are regulated early (ie, within 2 hours of CPC adhesion) and describe a role for Plk2 in the coordination of proliferation and early lineage commitment of CPCs as a key finding of this study. We also show that this early transcriptomic response is prompted by the rapid intracellular trafficking of the mechanosensor YAP and is associated with the facilitated endothelial differentiation of CPCs on LN ( Figure 7 ). Plk2 is a serine-threonine kinase that acts as a critical regulator of cell cycle progression. [50] [51] [52] In fact, the rapid decrease in Plk2 mRNA expression on LN-CPC contact preceded, and was causatively linked to, the reduced CPC proliferation, which was absent when Plk2 mRNA expression was preserved, such as in CPCs on FN or in Flag-Plk2-transfected CPCs on LN. Slowing of cell proliferation is associated with prolongation of the gap phases, the most critical phases for lineage programming and initiation of differentiation. 53 Considering the spontaneous differentiation that can be observed in pluripotent stem cells when the G 1 phase is prolonged 54, 55 and the prolongation of the G 1 phase because of delayed entry into the S phase that occurs in Plk2 -/-embryonic fibroblasts, 56 decreased expression of Plk2 may mark the timing of early lineage programming. Consistent with this hypothesis, we found that Plk2 expression inversely regulated the expression of cardiac lineage genes. Not only was the decrease in Plk2 mRNA in CPCs on LN followed by the Plk2 was among a set of genes that were regulated early on LN-CPC contact, and this early transcriptomic response was preceded by the phosphorylation, cytosolic retention, and degradation of YAP, which result in YAP inactivation. Inactivation of YAP occurs during embryonic stem cell differentiation, 45 whereas activated YAP regulates epidermal stem cell proliferation, 57 which are both in accordance with our observations in CPCs. We also found that the genes Plk2 is a target of microRNAs, and YAP was recently found to suppress microRNA processing when present in the nucleus. 60 One could speculate that YAP cytosolic trafficking may unleash microRNA activity, hence leading to Plk2 mRNA degradation.
The regulation of YAP localization within CPCs has recently been linked to the stiffness of the substrate, whereby a stiff substrate favors nuclear localization and a soft substrate favors cytosolic retention. 61 YAP nuclear localization correlates with increased cell spreading area, as previously reported in other cell types, 39 and shows within 3 to 5 hours of CPC contact with the substrate. For both CPC types studied, we found predominantly nuclear localization of YAP on FN versus predominantly cytosolic localization on LN.
However, in our model and in contrast to the reported findings, 61 differences in YAP intracellular localization and abundance were established within 15 to 120 minutes on plating (data not shown), which suggests a mechanism of signal transduction that is distinct from previously described pathways of mechanosensing. 39, 40 In fact, integrin-focal adhesion kinase-Src has recently been deemed responsible for YAP nuclear localization on FN through suppression of canonical Hippo signaling in MCF-10A cells. 62 CPCs respond to the biomechanical properties of their environment. Mechanical cues guide the endothelial differentiation of cardiosphere-derived CPCs, 18 and the stiffening of the ECM after cardiac injury enhances proliferation, but impairs differentiation, of SP-CPCs. 17 We observed a higher proliferation rate of CPCs on FN, but increased expression of cardiovascular lineage genes on LN, which was more pronounced for the endothelial lineage and translated into facilitated endothelial differentiation. These findings are consistent with a previous report on the role of FN in CPC expansion 15 and support that specific ECM proteins act as CPC fate cues. We found that CPCs that were primed under low serum conditions on LN for 24 hours and then exposed to endothelial differentiation conditions reached a higher degree of maturity after 3 weeks in culture than cells on FN.
This showed in the more robust expression of vWF protein and a higher capacity of tube formation. 10 But evidence is accumulating that cardiomyogenesis, endogenously or on cell transplantation, may be an unlikely event in the injured heart. Instead, using an advanced fate-tracking method, both c-kit + and SP-CPCs (ATP-binding cassette subfamily G member 2-expressing cells) have recently been shown to mostly produce endothelial cells. 5, 65 Although our data demonstrate a role for Plk2 in CPC lineage commitment and endothelial differentiation, this study does not address the in vivo implications of this regulation, which is the focus of our ongoing investigation. Such work is crucial in view of a potential therapeutic exploitation of the described pathway in the future (eg, to promote neovascularization by inducing endothelial differentiation of CPCs through Plk2 modulation).
In conclusion, we identify Plk2 as a coordinator of cell proliferation and early lineage commitment of CPCs, whose early regulation is associated with the facilitated endothelial differentiation of CPCs on LN downstream of YAP. These findings link early gene regulation to cell fate and provide novel insights into how CPC proliferation and differentiation are orchestrated. While we do not believe that Plk2 is the only responsible gene involved in the coordination of cell cycle and early lineage commitment in CPCs, an improved understanding of the molecular mechanisms of early lineage programming, which includes the identification of novel fate cues, as shown in this study, will ultimately lead to improved strategies for therapeutic regeneration.
Mochizuki, Ivanek, Kuster; Investigation, Mochizuki, Lorenz, Della Verde, Gaudiello; Resources, Ivanek; Writing-Original Draft, Mochizuki, Kuster; Writing-Review and Editing, all; Supervision, Kuster; Funding Acquisition, Mochizuki, Kuster. Figure S1 . Characterization of mouse and rat CPCs. 
Myh7b
Vwf Pecam1 
